Berbamine selectively induces apoptosis of human acute promyelocytic leukemia cells via survivin-mediated pathway
Authors:
- Zhi-Wen HeZHZhi-Wen He
- Dong WuDWDong Wu
- Rong-Zhen XuRXRong-Zhen Xu
Open Access
- 1 May 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 120 (9) , 802-806
Abstract
Currently, resistance and relapse are still major problems in acute promyelocytic leukemia (APL) cases. Thus, new agents that override the resistance are crucial to the development of curative therapies for APL. In this study, we investigated the effects of berbamine on the proliferation of APL cell line NB4 and its possible mechanisms. NB4 cells were treated with berbamine at different concentrations (0—64 μg/ml) for 72 hours. MTT assay was used to determine proliferation inhibition of NB4 cells. Cell apoptosis was evaluated by both flow cytometry (FCM) and morphological examination. PML/RAR-α and survivin mRNAs were measured by nested-RT-PCR and RT-PCR, respectively. Activated-caspase 3 was determined by FCM. Berbamine greatly inhibited the proliferation of NB4 cells in dose- and time-dependent manners, and its IC50 value was 3.86 μg/ml at 48 hours. Both morphological observations and FCM results showed that berbamine induced apoptosis of NB4 cells with concomitant increase of activated caspase-3 and decrease of survivin mRNA. After treatment with berbamine at 8 μg/ml for 48 hours, the percentage of apoptotic cells increased from 2.83% to 58.44% (PP Berbamine induces caspase-3-dependent apoptosis of leukemia NB4 cells via survivin-mediated pathway, suggesting that berbamine may be a novel potential agent against APL with a mechanism distinct from that of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO).Keywords
This publication has 17 references indexed in Scilit:
- Recurrent Extramedullary Relapse of Acute Promyelocytic Leukemia after Allogeneic Stem Cell Transplantation: Successful Treatment by Arsenic Trioxide in Combination with Local RadiotherapyInternational Journal of Hematology, 2006
- Relapse of acute promyelocytic leukemia with PML-RARα mutant subclones independent of proximate all-trans retinoic acid selection pressureLeukemia, 2006
- Berbamine: A novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activityLeukemia Research, 2006
- Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapyLeukemia, 2005
- PML Is a Direct p53 Target that Modulates p53 Effector FunctionsMolecular Cell, 2004
- The Role of PML in Tumor SuppressionCell, 2002
- Arsenic trioxide, a therapeutic agent for APLOncogene, 2001
- The function of PML in p53-dependent apoptosisNature Cell Biology, 2000
- Arsenic Trioxide as an Inducer of Apoptosis and Loss of PML/RARα Protein in Acute Promyelocytic Leukemia CellsJNCI: Journal of the National Cancer Institute, 1998
- Higher Frequency of Glutathione S-Transferase Deletions in Black Children With Acute Lymphoblastic LeukemiaBlood, 1997